Mifepristone (RU-486(®)) as a Schedule IV Controlled Drug—Implications for a Misleading Drug Policy on Women’s Health Care

Background: Mifepristone (RU-486) has been approved for abortion in Taiwan since 2000. Mifepristone was the first non-addictive medicine to be classified as a schedule IV controlled drug. As a case of the “misuse” of “misuse of drugs laws,” the policy and consequences of mifepristone-assisted aborti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Yi-Ping, Wang, Yun-Ju, Feng, Ling-Yi, Wu, Li-Tzy, Li, Jih-Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323789/
https://www.ncbi.nlm.nih.gov/pubmed/35886217
http://dx.doi.org/10.3390/ijerph19148363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323789/
https://www.ncbi.nlm.nih.gov/pubmed/35886217
http://dx.doi.org/10.3390/ijerph19148363

Ejemplares similares